| |
|
|
|
Fulgent Genetics Inc.  
|
|
5.6 0.25 (0.05%) |
06-21 16:00 |
|
Open: |
5.32 |
Pre close: |
5.35 |
Target:
|
7.42 
|
|
High: |
5.8277 |
Low: |
5.32 |
Resistance:
|
6.35
7.42
|
|
Volume: |
10,277 |
Market Cap: |
103M |
Support:
|
5.34
4.71
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.59
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
5.87 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
5.57 |
Stochastic Oscillator |
%K(14,3):
|
17.61 |
|
MA(250): |
4.58 |
%D(3): |
22.00 |
|
Average Volume(K) |
3-Month: |
1480
|
52-Week |
High:
|
7.85 |
|
10-Days: |
840 |
Low: |
3.02 |
|
RSI |
RSI(14):
|
45.65 |
Change(%): |
33.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.310 |
Return on Equity (ttm) |
-10.9 |
Shares Out. (M) |
18.32 |
|
EPS Est. Current Year |
0.140 |
Return on Assets (ttm) |
-5.3 |
Shares Float (M) |
7.77 |
|
EPS Est. Next Year |
0.320 |
PEG Ratio |
-5.93 |
% Held by Insiders |
68.90 |
|
EPS Est. Next Quarter |
0.070 |
Qtrly Rev. Growth |
15.4 |
% Held by Institutions |
6.74 |
|
Forward EPS |
0.070 |
Gross Profit (p.s.) |
0.581 |
Shares Short (K) |
12 |
|
Book Value (p.s.) |
2.730 |
EBITDA (p.s.) |
-0.138 |
P/E |
-18.06 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.05 |
|
Profit Margin |
-25.40 |
Operating Cash Flow
(M) |
1.67 |
P/S |
84091808.00 |
|
Operating Margin |
-21.29 |
Levered Free Cash Flow
(M) |
0.85 |
P/CF |
61.43 |
|
|
|
|
|
|
